Exploration of Pharmacophore in Chrysosplenol C as Activator in Ventricular Myocyte Contraction

ACS Medicinal Chemistry Letters

Volumn 6, Issue 7, 2015, Pages 758-763

  Venkateswararao, Eeda ^a   Son, Min Jeong ^a   Sharma, Niti ^a   Manickam, Manoj ^a   Boggu, PullaReddy ^a   Kim, Young Ho ^a   Woo, Sun Hee ^a   Jung, Sang Hun ^a  

^a Chungnam National University   (South Korea)

Author keywords

Chrysosplenol C; contractility; myosin activation; positive inotrope

Indexed keywords

7 CHLORO 2 (3 HYDROXYPHENYL) 3 METHOXY 4H CHROMEN 4 ONE; CHALCONE; CHRYSOSPLENOL C; DIMETHYL SULFOXIDE; HYDROXYL GROUP; INOTROPIC AGENT; MYOSIN ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ALDOL REACTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEBENZYLATION; DRUG SYNTHESIS; ENZYME ACTIVATION; HEART MUSCLE CONTRACTILITY; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; METHYLATION; MUSCLE FIBER CONTRACTION; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

MILIUSA BALANSAE; RATTUS;

EID: 84936867849     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00043     Document Type: Article

References (27)

1. Man, J. P.; Jugdutt, B. I. Systolic heart failure in the elderly: optimizing medical management Heart Fail. Rev. 2012, 17, 563-571
2. Gottdiener, J. S.; McClelland, R. L.; Marshall, R.; Shemanski, L.; Furberg, C. D.; Kitzman, D. W.; Cushman, M.; Polak, J.; Gardin, J. M.; Gersh, B. J.; Aurigemma, G. P.; Manolio, T. A. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The cardiovascular health study Ann. Int. Med. 2002, 137, 631-639
3. Berry, C.; Hogg, K.; Norrie, J.; Stevenson, K.; Brett, M.; McMurray, J. Heart failure with preserved left ventricular systolic function: a hospital cohort study Heart 2005, 91, 907-913
4. Teerlink, J. R. A novel approach to improve cardiac performance: cardiac myosin activators Heart. Fail. Rev. 2009, 14, 289-298
5. Lenzen, M. J.; Scholte op Reimer, W. J. M.; Boersma, E.; Vantrimpont, P. J. M. J.; Fallath, F.; Swedberg, K.; Cleland, J.; Komajda, M. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart failure survey Eur. Heart J. 2004, 25, 1214-1220
6. Hobbs, F. D. R; Kenkre, J. E.; Roalfe, A. K.; Davis, R. C.; Hare, R.; Davies, M. K. Impact of heart failure and left ventricular systolic dysfunction on quality of life Eur. Heart J. 2002, 23, 1867-1876
7. Malki, Q.; Sharma, N. D.; Afzal, A.; Ananthsubramaniam, K.; Abbas, A.; Jacobson, G.; Jafri, S. Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic function Clin. Cardiol. 2002, 25, 149-152
8. Philbin, E. F.; McCullough, P. A.; Dec, G. W.; DiSalvo, T. G. Length of stay and procedure utilization are the major determinants of hospital charges for heart failure Clin. Cardiol. 2001, 24, 56-62
9. Cohen-Solal, A.; Desnos, M.; Delahaye, F.; Emeriau, J. P.; Hanania, G. A national survey of heart failure in French hospitals Eur. Heart J. 2000, 21, 763-769
10. Bragadeesh, T. K. M.; Mathur, G.; Clark, A. L.; Cleland, J. G. F. Novel cardiac myosin activators for acute heart failure Expert Opin. Invest. Drugs 2007, 16, 1541-1548
11. Greaser, M. L.; Gergely, J. Purification and properties of the components from troponin J. Biol. Chem. 1973, 248, 2125-2133
12. Tobacman, L. S. Thin filament-mediated regulation of cardiac contraction Annu. Rev. Physiol. 1996, 58, 447-481
13. Felker, G. M.; O'Connor, C. M. Inotropic therapy for heart failure: an evidence-based approach Am. Heart J. 2001, 142, 393-401
14. Moiseyev, V. S.; Poder, P.; Andrejevs, N.; Ruda, M. Y.; Golikov, A. P.; Lazebnik, L. B.; Kobalava, Z. D.; Lehtonen, L. A.; Laine, T.; Nieminen, M. S.; Lie, K. I. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) Eur. Heart J. 2002, 23, 1422-1432
15. Orstavik, O.; Ata, S. H.; Riise, J.; Dahl, C. P.; Andersen, G. Ø.; Levy, F. O.; Skomedal, T.; Osnes, J. B.; Qviqstad, E. Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart Br. J. Pharmacol. 2014, 171, 5169-5181
16. Morgan, B. P.; Muci, A.; Lu, P.-P.; Qian, X.; Tochimoto, T.; Smith, W. W.; Garard, M.; Kraynack, E.; Collibee, S.; Suehiro, I.; Tomasi, A.; Valdez, S. C.; Wang, W.; Jiang, H.; Hartman, J.; Rodriguez, H. M.; Kawas, R.; Sylvester, S.; Elias, K. A.; Godinez, G.; Lee, K.; Anderson, R.; Sueoka, S.; Xu, D.; Wang, Z.; Djordjevic, N.; Malik, F. I.; Morgans, D. J., Jr. Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac myosin ACS Med. Chem. Lett. 2010, 1, 472-477
17. Malik, F. I.; Hartman, J. J.; Elias, K. A.; Morgan, B. P.; Rodriguez, H.; Brejc, K.; Anderson, R. L.; Sueoka, S. H.; Lee, K. H.; Finer, J. T.; Sakowicz, R.; Baliga, R.; Cox, D. R.; Garard, M.; Godinez, G.; Kawas, R.; Kraynack, E.; Lenzi, D.; Lu, P. P.; Muci, A.; Niu, C.; Qian, X.; Pierce, D. W.; Pokrovskii, M.; Suehiro, I.; Sylvester, S.; Tochimoto, T.; Valdez, C.; Wang, W.; Katori, T.; Kass, D. A.; Shen, Y.-T.; Vatner, S. F.; Morgans, D. J. Cardiac Myosin Activation: A potential therapeutic approach for systolic heart failure Science 2011, 331, 1439-1443
18. Huong, D. T.; Kamperdick, C.; Sung, T. V. Homogentisic acid derivatives from Miliusa balansae J. Nat. Prod. 2004, 67, 445-447
19. Son, M. J.; Kim, H. K.; Thu Huong, D. T.; Kim, Y. H.; Sung, T. V.; Cuong, N. M.; Woo, S. H. Chrysosplenol C increases contraction in rat ventricular myocytes J. Cardiovasc. Pharmacol. 2011, 57, 259-262
20. Pouget, C.; Fagnere, C.; Basly, J.-P.; Besson, A.-E.; Champavier, Y.; Habrioux, G.; Chulia, A.-J. Synthesis and aromatase inhibitory activity of flavanones Pharm. Res. 2002, 19, 286-291
21. Bennett, M.; Burke, A. J.; O'Sullivan, W. I. Aspects of the Algar-Flynn-Oyamada (AFO) reaction Tetrahedron 1996, 52, 7163-7178
22. Yamaguchi, S. Sulfuric acid esters III-IV. III. Sulfuric Acid esters of flavonoids. (part 2). Synthesis of sulfuric acid esters of polyhydroxyflavonols Nippon Kagaku Zasshi 1960, 81, 1332-1336
23. Meyer, N. D.; Haemers, A.; Mishra, L.; Pandey, H. K.; Pieters, L. A. C.; Vanden Berghe, D. A.; Vlietinck, A. J. 4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity J. Med. Chem. 1991, 34, 736-746
24. Simpson, T. H.; Garden, L. Chelate systems. Part I J. Chem. Soc. 1952, 4638-4644
25. Kidd, D. Potential bronchodilators in the flavanoid series J. Chem. Soc. 1962, 5121-5125
26. Wei, G.-J.; Sheen, J.-F.; Lu, W.-C.; Hwang, L. S.; Ho, C.-T.; Lin, C.-I. Identification of sinensetin metabolites in rat urine by an isotope-labeling method and ultra high performance liquid chromatography-electrospray ionization mass spectrometry J. Agric. Food Chem. 2013, 61, 5016-5021
27. Pollard, T. D. Myosin purification and characterization Methods Cell Biol. 1982, 24, 333-371